HARVARD BIOSCIENCE INC — Director's Dealing 2023

May 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2023-05-22

Reporting Person: Loewald Thomas W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-22	Common Stock	A	25554	$0.00	Acquired	249439	Direct

Footnotes

F1: Represents an award of 25,554 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 15, 2023, immediately prior to the commencement of such meeting, and (ii) May 22, 2024.

F2: Includes (a) the award described in footnote (1) above and (b) 223,885 shares of common stock held by the Reporting Person.